United Therapeutics | UTHR - Operating Expenses



United Therapeutics reported $521.7M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Amarin USD 58.77M 56.06M Mar/2025
Ardelyx USD 112.06M 4.06M Jun/2025
Baxter International USD 2.54B 29M Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
BioMarin Pharmaceutical USD 548.52M 27.27M Jun/2025
Gilead Sciences USD 4.35B 80M Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
Halozyme Therapeutics USD 123.28M 48K Jun/2025
Insmed USD 361.29M 20.33M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
J&J USD 16.8B 8.54B Jun/2025
Moderna USD 1.04B 113M Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
PTC Therapeutics USD 213.73M 7.86M Jun/2025
Regeneron Pharmaceuticals USD 2.6B 159.1M Jun/2025
Sarepta Therapeutics USD 495.51M 549.73M Jun/2025
Teva Pharmaceutical Industries USD 3.28B 95M Jun/2025
United Therapeutics USD 521.7M 110.1M Jun/2025
Vertex Pharmaceuticals USD 1.81B 71.4M Jun/2025